Effective testing at the point of care
The BD Veritor™ Plus System offers what your organization needs to conduct antigen testing for respiratory infections and can help you successfully implement a reliable diagnostic testing program.
COVID‑19 (SARS‑CoV‑2)* rapid antigen testing
BD Veritor™ Plus System
Used as part of a comprehensive coronavirus mitigation program, fast, easy-to-use testing for SARS-CoV-2 (the novel or new coronavirus that causes COVID-19) provides health care workers information they can use to actively detect the virus and decrease the likelihood of spread.
What is COVID‑19?
There are seven known human coronaviruses¹. SARS-CoV-2, more commonly referred to as COVID-19, is the coronavirus that caused the COVID-19 pandemic².
In COVID-19, the name reflects the following:²
To learn more about how to slow the spread of COVID-19, visit the Government of Canada website for more information.
Why rapid point-of-care testing matters
As the global healthcare community searches for effective methods for addressing COVID-19, the important role of testing is becoming more apparent. There are currently two kinds of testing available for SARS-CoV-2: diagnostic testing that detects either genetic material (RNA) or proteins (antigens) from the infecting virus, and antibody testing that detects the body’s immune response to infection and/or vaccination.
The BD Veritor™ Plus System provides simple and reliable rapid antigen testing at the point-of-care.
Types of respiratory diagnostic testing
Rapid antigen test
Detects proteins (antigens) from the infecting virus
Molecular diagnostic (PCR) test
Detects genetic material (RNA) from the infecting virus
Detects the body’s immune response to infection (antibodies)
BD Veritor™ System for Rapid Detection of SARS‑CoV‑2*
The BD Veritor™ System for Rapid Detection of SARS‑CoV‑2* antigen test detects nucleoproteins from the SARS‑CoV‑2 virus in as little as 15 minutes⁴, and can be conducted at the point-of-care.
The BD Veritor™ Plus System provides rapid, reliable results, and offers one-button functionality for workflow flexibility, allowing health care professionals to confidently use the Analyzer.
Simple sample collection
Rapid, reliable results
Reporting options available
How to perform COVID‑19 testing with the BD Veritor™ Plus System*
The BD Veritor™ System for Rapid Detection of SARS‑CoV‑2* antigen test detects proteins from the SARS‑CoV‑2 virus. A nasal swab is used to collect the specimen from a patient suspected of having COVID‑19. The sample is prepared, added to the assay cartridge, incubated and then interpreted by the Analyzer.
For complete instructions for use, refer to our user documentation.
To learn more about how to administer rapid antigen testing with the BD Veritor™ Plus System, see our simple user guides in the resource library.
BD Veritor™ Plus System ordering
As your facility continues to provide valuable rapid diagnostic testing, you may need to reorder. Please click here for more information.